Sph-biocad (hk) Limited
Clinical trials sponsored by Sph-biocad (hk) Limited, explained in plain language.
-
New psoriasis drug shows promise in major trial
Disease control CompletedThis study tested a new drug, netakimab, in 202 Chinese adults with moderate to severe plaque psoriasis. Participants received either netakimab or a placebo to see if the drug could improve skin symptoms. The main goal was to measure at least a 75% improvement in psoriasis severi…
Phase: PHASE3 • Sponsor: SPH-BIOCAD (HK) Limited • Aim: Disease control
Last updated May 26, 2026 10:27 UTC
-
New drug shows promise for back pain from ankylosing spondylitis
Disease control CompletedThis study tested a drug called netakimab in 113 Chinese adults with active ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. Participants received either netakimab or a placebo to see if the drug could reduce symptoms. The main goal was to measure …
Phase: PHASE3 • Sponsor: SPH-BIOCAD (HK) Limited • Aim: Disease control
Last updated May 20, 2026 11:57 UTC